Epichem, a wholly owned subsidiary of ASX listed biotech hopeful Pharmaust, has reached the pinnacle of its 13 year existence with the opening of its new state of the art chemistry lab in Technology Park, Bentley. The new lab which is double the size of the old one previously operated on site at Murdoch University, cost $1.6m and boasts a serious brains trust of 13 PHD’s amongst its 18 staff.
15/02/2016 - 14:02
Pharmaust opens new drug lab at Technology Park
15/02/2016 - 14:02
Related Data & Insights
-
-
Rank Company Revenue th PharmAust $842k 200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned People
Related Articles
21 Jun 2024
PharmAust taps investors for $10m
31 May 2024
Shares rise following Thurn return
17 May 2024
Board Moves May 17, 2024
17 May 2024
PharmAust receives FDA approval
24 Apr 2024
Board Moves, April 24 2024
23 Apr 2024
PharmAust CEO resigns
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX